Explore High-Growth Investment Opportunities

The Celadon Pharmaceuticals AMC is the world's first regulated, securitised, and tradable pharmaceutical cannabinoid investment product.

The investment provides exposure to Celadon Pharmaceuticals Ltd, a company focused on delivering pharmaceutical cannabinoid solutions to patients where conventional treatments have failed.

AIERO Ventures is a specialized investment Cell targeting high-growth, high-margin technology opportunities across the Integrated Aviation and Aerospace Ecosystem (IAAE). By focusing on the enabling technologies and services—such as AI, predictive maintenance, and cloud solutions—that improve efficiency, safety, and profitability across the entire value chain (airlines, airports, MROs, and ATC), AIERO captures significant untapped value beyond traditional airline investment.